Pcn149 - Cost-Effectiveness of Brca1/2 Mutation Profiling to Target Olaparib Use in Patients With Metastatic Breast Cancer in Japan
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.232
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV